Dan Brownell
Senior Director, Research & Development AOBiome
Dan Brownell is the Senior Director of R&D at AOBiome Therapeutics, responsible for leading our preclinical and R&D programs since joining in 2018. Dan brings 20 years of scientific experience, with a focus on the use of microorganisms to achieve positive outcomes. At AOBiome, Dan leads a high-performing team of scientists responsible for better understanding the mechanisms of action of AOB and their use as a treatment for disease.
Prior to AOBiome, Dan held diverse roles within the biotech community, including in the fields of rapid diagnostics, synthetic biology, and biofuels.
Seminars
Wednesday 28th January 2026
Unpacking Mechanistic Insights to Strengthen Microbiome Therapeutic Development
11:30 am
- Explore how AOBiome Therapeutics’ recent metabolomic and preclinical work is shaping a deeper understanding of therapeutic action in dermatological indications
- Share lessons learned from bridging mechanistic hypotheses with clinical trial design to improve signal detection and separate from placebo
- Discuss how mechanistic clarity can inform formulation and delivery strategies, and open doors to new indications
